KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Inventory: 2016-2024

Historic Change in Inventory for Sarepta Therapeutics (SRPT) over the last 9 years, with Dec 2024 value amounting to $395.2 million.

  • Sarepta Therapeutics' Change in Inventory rose 17.69% to $83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $481.2 million, marking a year-over-year increase of 46.89%. This contributed to the annual value of $395.2 million for FY2024, which is 167.52% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Change in Inventory of $395.2 million as of FY2024, which was up 167.52% from $147.7 million recorded in FY2023.
  • Sarepta Therapeutics' Change in Inventory's 5-year high stood at $395.2 million during FY2024, with a 5-year trough of $50.8 million in FY2022.
  • In the last 3 years, Sarepta Therapeutics' Change in Inventory had a median value of $147.7 million in 2023 and averaged $197.9 million.
  • As far as peak fluctuations go, Sarepta Therapeutics' Change in Inventory crashed by 39.38% in 2022, and later skyrocketed by 190.89% in 2023.
  • Sarepta Therapeutics' Change in Inventory (Yearly) stood at $60.6 million in 2020, then surged by 38.28% to $83.8 million in 2021, then slumped by 39.38% to $50.8 million in 2022, then spiked by 190.89% to $147.7 million in 2023, then spiked by 167.52% to $395.2 million in 2024.